Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 83

BlueVine bolsters series E to $72m

Corporate venturing units M12 and Nationwide Ventures added $12m to small business finance provider BlueVine's series E round.

Aug 9, 2018

Freee accounts for $60m series E

The accounting software developer added Line, Mitsubishi UFJ and Life Card to a roster of shareholders that already included Salesforce, Sharp, Recruit and SBI.

Aug 9, 2018

Namely spells out $60m series E round

The Vayner/RSE-backed human resources software provider has now raised a total of approximately $200m.

Aug 6, 2018

Deezer seizes $185m

Access Industries, Orange and Rotana have committed capital to the music streaming platform, which raised the cash at a $1.16bn valuation.

Aug 3, 2018

Peloton Interactive pushes its way to $550m

The exercise equipment and service provider has raised series F financing from investors including Comcast NBCUniversal at a $4.15bn valuation.

Aug 3, 2018

CapitalG goes to Freshworks in $100m round

Freshworks, the customer engagement software developer formerly known as Freshdesk, secured the funding at a $1.5bn valuation.

Aug 2, 2018

Grab ramps up latest round to $2bn

A $1bn investment by Toyota was matched by backers including Ping An and Naver, valuing the on-demand ride service at $11bn post-money.

Aug 2, 2018

Optoro gets $75m return in latest round

The UPS-backed returns optimisation platform developer has now raised $190m altogether, Franklin Templeton having led the new round.

Aug 1, 2018

Agendia generates $35m

Athyrium Capital Management provided the capital for Debiopharm and Axa-backed breast cancer diagnostics system developer Agendia.

Jul 30, 2018

Sutro sucks in series E funding

Merck & Co, Celgene, Amgen and Eli Lilly all took part in an $85.4m round that boosted the cancer drug developer's total funding to more than $175m.

Jul 27, 2018

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here